Abstract

The overall response in both therapeutic combinations were relatively with equal effect. In the first group, 45.7% of patients were cured and relapse was seen in 14.2% of the patients and no patients develop worse subsequent relapse. In the second group, the cure rate was 47 and relapse recorded in 11.4% with no development of worse course. While in third group none patients cured during the treatment course duration and the worsen clinical status developed in 77.1% of the patients. Mild skin irritation, redness, dryness and itching were developed as adverse effects in 91.4% of patients in the first 5 minutes of drugs application in group A and B. Dryness developed in 20% of the placebo group. However, the treatment was well tolerated in patients receiving active treatments

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.